Risk assessment of esophageal adenocarcinoma using ?-H2AX assay.
Ontology highlight
ABSTRACT: BACKGROUND:Mutagen-induced DNA damage as measured in peripheral blood lymphocytes (PBL) has been associated with increased risks of cancers. The formation of ?-H2AX is an early cellular response to DNA double-strand breaks (DSB). We hypothesize that higher level of radiation-induced ?-H2AX in PBLs may be associated with an increased risk of esophageal adenocarcinoma. METHODS:Laser scanning cytometer-based immunocytochemical method was used to measure baseline and irradiation-induced ?-H2AX levels in PBLs from 211 patients with esophageal adenocarcinoma and 211 healthy controls. The ratio of induced ?-H2AX level to baseline level was used to evaluate individual susceptibility to DSBs. Relative risks for esophageal adenocarcinoma associated with ?-H2AX were assessed by multivariable logistic regression analysis. RESULTS:Radiation-induced ?-H2AX level and the ?-H2AX ratio were significantly higher in cases than in controls. Dichotomized at the median in controls, a significantly increased risk for esophageal adenocarcinoma was observed in association with high ?-H2AX ratio [OR = 2.94; 95% confidence interval (CI), 1.83-4.72]. Quartile analyses showed significant dose-response associations between higher ?-H2AX ratio and increased risk of esophageal adenocarcinoma (Ptrend, 1.64E-06). In addition, joint effect between ?-H2AX ratio and smoking was observed: smokers who had high ?-H2AX ratio exhibited the highest risk of esophageal adenocarcinoma (OR = 5.53; 95% CI, 2.71-11.25) compared with never smokers with low ?-H2AX ratio. CONCLUSION:Radiation-induced DNA damage assessed by ?-H2AX ratio is associated with an increased risk of esophageal adenocarcinoma. IMPACT:?-H2AX assay is a new and robust method to measure DSB damage in PBLs, which can be used to assess mutagen sensitivity and esophageal adenocarcinoma risk.
SUBMITTER: Xu E
PROVIDER: S-EPMC3824382 | biostudies-literature | 2013 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA